Nora Ruel

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist (2024)
Alexis LeVee, Megan Wong, Sarah Flores, Nora Ruel, Heather McArthur, James Waisman, Joanne Mortimer
Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis. The oncologist 29 (7) (2024)
Ferdynand J Kos, Paul H Frankel, Mihaela C Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey, Nora Ruel, Daphne Stewart, Thanh H Dellinger, Don J Diamond
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer. Cancer research communications (2023)
Ramy Sedhom, Betty R Ferrell, Nora Ruel, Marianna Koczywas, Vincent Chung, Thomas J Smith
Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials. JNCI cancer spectrum 4 (6) (2020)